Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease

•The majority of teprotumumab-treated patients experienced otologic symptoms.•Most otologic symptoms resolved after therapy, with the exception of hearing loss.•Baseline hearing loss portends higher risk of worsening sensorineural hearing loss.